Merdad Parsey

Companies

• Ardelyx (United States)Board member May 13, 2025 to now¹
• ArriVent BioPharma, Inc.Board member Apr 29, 2025 to now²
• Gilead SciencesChief Medical Officer Nov 6, 2019 to Dec 11, 2024³
• Sagimet Biosciences Inc.Board member Jul 13, 2023 to Jun 7, 2024⁴
• Arcus BiosciencesBoard member Jul 13, 2020 to Jul 13, 2020⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• GSGilead Sciences GILD82,850 shares⁶$12.9M at $156.25Dec 10, 2024
• AUArdelyx (United States) ARDX83,746 shares⁷$259.6K at $3.10Jun 16, 2026
• SBSagimet Biosciences Inc. SGMT12,794 shares⁸$112.9K at $8.82Jul 18, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 16, 2026Granted 26,455 shares of Ardelyx (United States)⁷
• Jun 18, 2025Granted 15,235 shares of Ardelyx (United States)⁹
• Apr 28, 2025Granted 42,056 shares of Ardelyx (United States)¹⁰
• Dec 10, 2024Shares withheld for tax 1,771 shares at $92.34 of Gilead Sciences⁶
• Dec 10, 2024Exercised options 3,820 shares of Gilead Sciences⁶
• Nov 27, 2024Sold 10,399 shares at $92.00 of Gilead Sciences¹¹
• Nov 27, 2024Sold 3,199 shares at $91.80 of Gilead Sciences¹¹
• Nov 27, 2024Sold 5,200 shares at $91.80 of Gilead Sciences¹¹
• Nov 27, 2024Sold 88,119 shares at $92.00 of Gilead Sciences¹¹
• Nov 27, 2024Sold 57,294 shares at $91.79 of Gilead Sciences¹¹
• Nov 27, 2024Exercised options 88,119 shares at $65.38 of Gilead Sciences¹¹
• Nov 27, 2024Exercised options 57,294 shares at $57.92 of Gilead Sciences¹¹
• Nov 6, 2024Sold 5,000 shares at $91.50 of Gilead Sciences¹²
• Nov 6, 2024Sold 20,590 shares at $91.50 of Gilead Sciences¹²
• Nov 6, 2024Exercised options 25,000 shares at $57.92 of Gilead Sciences¹²
• Oct 1, 2024Sold 2,000 shares at $83.83 of Gilead Sciences¹³
• Sep 12, 2024Sold 21,246 shares at $84.50 of Gilead Sciences¹⁴
• Sep 12, 2024Exercised options 25,000 shares at $57.92 of Gilead Sciences¹⁴
• Sep 10, 2024Shares withheld for tax 1,766 shares at $81.44 of Gilead Sciences¹⁵
• Sep 10, 2024Exercised options 3,821 shares of Gilead Sciences¹⁵
• Jul 1, 2024Sold 2,000 shares at $68.63 of Gilead Sciences¹⁶
• Jun 10, 2024Shares withheld for tax 1,744 shares at $65.25 of Gilead Sciences¹⁷
• Jun 10, 2024Exercised options 3,820 shares of Gilead Sciences¹⁷
• Apr 1, 2024Sold 2,000 shares at $72.96 of Gilead Sciences¹⁸
• Mar 10, 2024Shares withheld for tax 4,803 shares at $75.12 of Gilead Sciences¹⁹